C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib-Reference-Cited by-同舟云学术

C-terminal variants in CDC42 drive type I interferon-dependent autoinflammation in NOCARH syndrome reversible by ruxolitinib

Published:2023-11 Issue: Volume:256 Page:109777
ISSN:1521-6616
Container-title:Clinical Immunology
language:en
Short-container-title:Clinical Immunology

Author:

Kapp Friedrich G.,Kretschmer Stefanie,Beckmann Cora C.A.,Wäsch Lena,Molitor Anne,Carapito Raphaël,Schubert Mario,Lucas Nadja,Conrad Solène,Poignant Sylvaine,Isidor Bertrand,Rohlfs Meino,Kisaarslan Ayşenur Paç,Schanze Denny,Zenker Martin,Schmitt-Graeff Annette,Strahm Brigitte,Peters Anke,Yoshimi Ayami,Driever Wolfgang,Zillinger Thomas,Günther Claudia,Maharana Shovamayee,Guan Kaomei,Klein Christoph,Ehl Stephan,Niemeyer Charlotte M.,Unal Ekrem,Bahram Seiamak,Hauck Fabian,Lee-Kirsch Min Ae,Speckmann Carsten

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference33 articles.

1. A novel disorder involving dyshematopoiesis, inflammation, and HLH due to aberrant CDC42 function;Lam;J. Exp. Med.,2019

2. Severe autoinflammation in 4 patients with C-terminal variants in cell division control protein 42 homolog (CDC42) successfully treated with IL-1β inhibition;Gernez;J. Allergy Clin. Immunol.,2019

3. A toxic palmitoylation of Cdc42 enhances NF-κB signaling and drives a severe autoinflammatory syndrome;Bekhouche;J. Allergy Clin. Immunol.,2020

4. A new patient with NOCARH syndrome due to CDC42 defect;He;J. Clin. Immunol.,2020

5. Infantile myelofibrosis and myeloproliferation with CDC42 dysfunction;Verboon;J. Clin. Immunol.,2020

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inborn errors of immunity: A field without frontiers;Immunological Reviews;2023-12-08